Understanding these can help patients navigate the complexities of their insurance plans and ensure they receive the necessary coverage for their treatment
supply chain." Asked about the status of the investigation into the counterfeit Ozempic, an FDA spokesperson said there were no updates to the original alert
Aug 11: J&Js Janssen got the FDAs greenlight for its PARP inhibitor Akeega (niraparib and abiraterone acetate), which is now authorized to treat BRCA-mutated metastatic castration-resistant prostate cancer
The journey from discovery of the GLP-1 hormone to treatments for diabetes and then obesity was a long and stuttering one, spanning more than four decades and involving hundreds of researchers across academia and the pharmaceutical industry
At the studys initiation, 29% of patients were prescribed semaglutide, 49.7% dulaglutide, 34% liraglutide, 12.7% exenatide, 4.6% tirzepatide and 2.1% lixisenatide